Compile Data Set for Download or QSAR
maximum 50k data
Found 52 of ic50 data for polymerid = 5427,50000873
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50598820(CHEMBL5191665)
Affinity DataIC50:  7nMAssay Description:Inhibition of full length Nano-luc fused EPHB3 in human HEK-293T cells incubated for 2 hrs by cell based NanoBRET target engagement assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50598829(CHEMBL5203261)
Affinity DataIC50:  7nMAssay Description:Inhibition of full length Nano-luc fused EPHB3 in human HEK-293T cells incubated for 2 hrs by cell based NanoBRET target engagement assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50100316(CHEMBL3321809)
Affinity DataIC50:  7nMAssay Description:Inhibition of full length Nano-luc fused EPHB3 in human HEK-293T cells incubated for 2 hrs by cell based NanoBRET target engagement assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50299218(8-(2-Methoxyphenyl)-1-methyl-7-(2'-methyl-5'-hydro...)
Affinity DataIC50:  15nMAssay Description:Inhibition of EphB3 by [gamma33-P]ATP based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50598810(CHEMBL5202826)
Affinity DataIC50:  18nMAssay Description:Inhibition of full length Nano-luc fused EPHB3 in human HEK-293T cells incubated for 2 hrs by cell based NanoBRET target engagement assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50538442(CHEMBL4638981)
Affinity DataIC50:  20nMAssay Description:Inhibition of EPHB3 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50538438(CHEMBL4640297)
Affinity DataIC50:  51nMAssay Description:Inhibition of EPHB3 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311312(CHEMBL1078739 | N-(2-chlorophenyl)-6-phenylimidazo...)
Affinity DataIC50:  60nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311306(CHEMBL1078214 | N-(2-chlorophenyl)-5-(piperidin-1-...)
Affinity DataIC50:  63nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311302(CHEMBL1078107 | N-(2-chlorophenyl)-5-phenylpyrazol...)
Affinity DataIC50:  66nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311303(CHEMBL1077571 | N-(2-chlorophenyl)-5-(dimethylamin...)
Affinity DataIC50:  77nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311316(CHEMBL1077739 | LDN-211904 | N-(2-chlorophenyl)-6-...)
Affinity DataIC50:  79nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311313(CHEMBL1078840 | N-(2-chlorophenyl)-6-(piperidin-1-...)
Affinity DataIC50:  87nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311318(6-bromo-N-(2-chlorophenyl)-2-methylimidazo[1,2-a]p...)
Affinity DataIC50:  173nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311301(CHEMBL1080959 | N-(2-chlorophenyl)-5-methoxypyrazo...)
Affinity DataIC50:  190nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311304(CHEMBL1078108 | N-(2-chlorophenyl)-5-(1H-pyrrol-1-...)
Affinity DataIC50:  200nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311317(CHEMBL1077740 | N-(2-chlorophenyl)-6-(4-hydroxypip...)
Affinity DataIC50:  228nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311305(CHEMBL1078109 | N-(2-chlorophenyl)-5-morpholinopyr...)
Affinity DataIC50:  240nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311296(CHEMBL1081498 | N-(2-chlorophenyl)-5-methylpyrazol...)
Affinity DataIC50:  260nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50357333(CHEMBL1916891)
Affinity DataIC50:  350nMAssay Description:Inhibition of EPHB3 relative to controlMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311311(CHEMBL1078738 | N-(2-chlorophenyl)imidazo[1,2-a]py...)
Affinity DataIC50:  460nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)
Affinity DataIC50:  741nMAssay Description:Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311288(CHEMBL1078785 | N-(2-chlorophenyl)pyrazolo[1,5-a]p...)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50363957(CHEMBL1952210)
Affinity DataIC50:  1.09E+3nMAssay Description:Inhibition of EphB3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50182212(7-(4-fluorophenylamino)-1-((1S,3R)-3-hydroxycyclop...)
Affinity DataIC50:  1.25E+3nMAssay Description:Inhibitory activity against EphB3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)
Affinity DataIC50:  1.83E+3nMAssay Description:Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311299(5-chloro-N-(2-chlorophenyl)pyrazolo[1,5-a]pyridine...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50134791(CHEMBL3734863)
Affinity DataIC50:  3.90E+3nMAssay Description:Displacement of biotinylated ephrin-B1-Fc from EphB3 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50428059(CHEMBL2322989)
Affinity DataIC50:  4.40E+3nMAssay Description:Displacement of ephrin-B1-Fc from EphB3 receptor Fc ectodomain (unknown origin) after 1 hr by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM13533(1-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3...)
Affinity DataIC50:  9.40E+3nMAssay Description:Inhibition of EPHB3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50135286(CHEMBL3745885)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50519662(CHEMBL4438748)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of recombinant human EphB3 (599 to 920 residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Mus musculus)
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50551201(CHEMBL4761556)
Affinity DataIC50:  1.10E+4nMAssay Description:Displacement of biotinylated ephrin-B1-Fc from mouse EphB3 Fc preincubated for 1 hr followed by ephrin-B1-FC addition and measured after 4 hrs by ELI...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311295(CHEMBL1080223 | N-(2-chlorophenyl)-4-methylpyrazol...)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311297(CHEMBL1081499 | N-(2-chlorophenyl)-6-methylpyrazol...)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311310(CHEMBL1077850 | N-(2-chlorophenyl)pyrazolo[1,5-a]p...)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311292(CHEMBL1077512 | N-(2-cyanophenyl)pyrazolo[1,5-a]py...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311291(CHEMBL1078902 | N-(2-(trifluoromethyl)phenyl)pyraz...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311290(CHEMBL1079075 | N-(2,3-dichlorophenyl)pyrazolo[1,5...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311293(2-chloro-N-(pyrazolo[1,5-a]pyridin-3-yl)benzamide ...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311294(2-chloro-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)anil...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311298(4-chloro-N-(2-chlorophenyl)pyrazolo[1,5-a]pyridine...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311300(6-chloro-N-(2-chlorophenyl)pyrazolo[1,5-a]pyridine...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311307(5-(benzyloxy)-N-(2-chlorophenyl)pyrazolo[1,5-a]pyr...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311315(CHEMBL1077738 | N-(2-chlorophenyl)-2-methyl-6-phen...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311314(CHEMBL1078542 | N-(2-methoxyphenyl)-6-phenylimidaz...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311309(CHEMBL1078239 | N-(2-chlorophenyl)-[1,2,3]triazolo...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311308(CHEMBL1078238 | N-(2-chlorophenyl)-1H-indazole-3-c...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50311289(CHEMBL1078965 | N-(2-fluorophenyl)pyrazolo[1,5-a]p...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-B receptor 3(Homo sapiens (Human))
Repare Therapeutics

Curated by ChEMBL
LigandPNGBDBM50359359(CHEMBL1929238)
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of EPHB3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: